Effect of 17-β estradiol on the expression of inducible nitric oxide synthase in parent and tamoxifen resistant T47D breast cancer cells

Iranian Journal of Pharmaceutical Research

Volumn 8, Issue 2, 2009, Pages 125-133

  Ostad, Seyed Nasser ^a   Maneshi, Andisheh ^a   Sharifzadeh, Mohammad ^a   Azizi, Ebrahim ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Estradiol; Estrogen; Nitric oxide synthase; Tamoxifen

Indexed keywords

ESTRADIOL; INDUCIBLE NITRIC OXIDE SYNTHASE; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER RESISTANCE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; SERUM;

EID: 67651166746     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Alalami O and Martin JHJ. ZR-75-1 human breast cells: expression of inducible nitric oxide synthase and effect of tamoxifen and phorbol ester on nitric oxide production. Cancer Let. (1998) 123: 99-105
2. Al-Hajji J, Larsson B and Barta S. Nitric oxide synthase in rabbit uterus and vagina: hormonal regulation and functional significance. Biology of Reproduction (2000) 62: 1387-92
3. Andrade SP, Hart HR and Piper PJ. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Brit. J. Pharmacol. (1992) 107: 1092-1097
4. Bani D, Masini E, Bello MG, Bigazzi M and Sacchi TB. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cell lines. Cancer Res. (1995) 55: 5272-5275
5. Bredt DS and Snyder SH. Nitric oxide: a physiologic messenger molecule. Ann. Rev. Chem. (1994) 63: 175-195
6. Calmels S, Hainaut P and Ohshima H. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res. (1997) 57: 3365-3369
7. Cendan JC, Topping DL, Pruitt J, Snowdy S, Copeland EM and Lind DS. Inflammatory mediators stimulate arginine transport and arginine-derived nitric oxide production in a murine breast cancer cell line. J. Surg. Res. (1996) 60: 284-288
8. Cui S, Reichner JS, Mateo RB and Albina JE. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or independent mechanisms. Cancer Res. (1994) 54: 2462-2467
9. Laskin. D.J., Laskin. L.L. Cellular and Molecular Biology of Nitric Oxide. Marcel Dekker. Inc. New york (1999) 1-225
10. Dong V, Staroselsky AH, Qi X, Xie K and Fidler IJ. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis 1735 murine melanoma cells. Cancer Res. (1994) 54: 789-793
11. Drapier J and Hibbs Jr JB. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells: inhibition involves the iron-sulfur prosthetic group and is reversible. J. Clin. Invest. (1986) 78: 790-795
12. Duenas-Gonzalez A, Isales CM, Del Mar Abad-Hernandez M, Gonzalez-Sarmiento R, Sangueza O and Rodriguez-Commes J. Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Mol. Pathol. (1997) 10: 645-649
13. Duenas-Gonzalez A, Isales CM, del Mar Abad-Hernandez M, Gonzalez-Sarmiento R, Sangueza O and Rodriguez-Commes J. Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Modern Pathol. (1997) 10: 645-649
14. Friedl A and Jordan VC. Oestradoil stimulates growth of oestrogen receptor-negative MDA-MB-231 breast cancer cells in immunodeficient mice by reducing cell loss. Eur. J. Cancer (1994) 30A: 1559-1564
15. Guinee VF, Olsson H, Moller T. Effect of pregnancy on prognosis for young women with breast cancer. Lancet (1994) 343: 1587-1589
16. Issacs JH. Cancer of breast in pregnancy. Surg. Clin. North. Am. (1995) 75: 47-51
17. Jenkins DC, Charles IG, Baylis SA, Lelchuk R, Radomski MW and Moncada S. Human colon cancer cell lines show a divers pattern of nitric oxide synthase expression and nitric oxide generation. Brit. J. Cancer (1994) 70: 847-849
18. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC and Moncada S. Roles of nitric oxide in tumor growth. Proc. Nat. Acad. Sci. USA (1995) 92: 4392-4396
19. Jordan VC. Long-term Tamoxifen Treatment for Breast Cancer. University of Wisconsin Press, Madison (1994) 1-289
20. Kamp M, Alexaki VI, Notas G, Nifli AP, Nistikaki A, Hatzogluou A, Bakogeorgou E, Kouimtzoglou E, Blekas G, Boskou D, Gravanis A and Gastanas E. Antiprolifrative and apoptotic effect of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res. (2004) 6: R63-R67
21. Knowles RG and Moncada S. Nitric oxide synthase in mammals. Biochem. J. (1994) 298: 249-58
22. Leonessa F, Boulay V, Wright A, Thompson EW, Brunner N and Clarke R. The biology of breast tumor progression: acquisition of hormone-independence and resistance to cytotoxic drugs. Acta Oncol. (1992) 31: 115-123
23. Long B, Mc Kibben BM, Lynch M and van den Berg HW. Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line. Brit. J. Cancer (1992) 65: 865-869
24. Martin JHJ, Alalami O and van den Berg HW. Reduced expression of endothelial and inducible nitric oxide synthase in a human breast cancer cell line which has acquired estrogen independence. Cancer Let. (1999) 144: 65-74
25. Martin JHJ and Edwards SW. Changes in mechanisms of monocyte/macrophage mediated cytotoxicity during culture, reactive oxygen intermediates are involved in monocytemediated cytotoxicity whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J. Immunol. (1993) 150: 3478-3486
26. Matsumi H, Yano T, Osuga Y, Kugu K, Tang X, Xu JP, Yano N, Kurashima Y, Ogura T, Tsutsumi O, Koji, Esumi H and Taketani Y. Regulation of nitric oxide synthase to promote cytostasis in ovarian follicular development. Biology of Reproduction (2000) 63: 141-6
27. Moncada S, Palmer RMJ and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. (1991) 43: 109-42
28. Palmer RM, Ferrige AG and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 327: 524-6
29. Petal P, Varghes E, Ding G, Fan S, Kapsi A, Reddy K, Franki N, Nahar N and Singhal P. Transforming growth factor beta induces mesangial cell apoptosis through No- and p-53 -dependent and -independent pathway. J. Invest. Med. (2000) 48: 403-10
30. Posch K, Schemidet K and Graier WF. Selective stimulation of L-arginine uptake contributes to shear stress-induced formation of nitric oxide. Life Sci. (1999) 64: 663-70
31. Postovit LM, Adams MA, Lash GE, Heaton JP and Graham CH. Oxygen-mediated regulation of tumor cell invasiveness involvement of a ntric oxide signaling pathway. J. Biol. Chem. (2002) 227: 35730-35737
32. Sandoval M, Liu X, Oliver PD, Zhang XJ, Clark DA and Miller MJS. Nitric oxide induces apoptosis in a human colonic epithelial cell line, T84, Mediat. Inflammation (1995) 4: 248-250
33. Sherman PA, Laubach VE, Reep BR and Wood ER. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumour cell line. Biochem. (1993) 32: 11600-11605
34. Stuehr DJ and Nathan CF. Nitric oxide, a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. (1989) 169: 1543-1555
35. Stuehr DJ, Kwon NS, Nathan CF, Griffith OW, Feldman PL and Wiseman J. N-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J. Biol. Chem. (1991) 266: 6259-6263
36. Iwasaki T, Higashiyama M, Kuriyama K, Sasaki A, Mukai M, Shinkai K, Horai T, Matsuda H and Akedo H. NG nitro- l-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model. Jpn. J. Cancer Res. (1997) 88: 861-866
37. Thomsen LL, Miles DW, Hupperfield L, Borow LG, Knowles RG and Moncada S. Nitric oxide synthasae activity in human breast cancer. Brit. J. Cancer (1995) 72: 41-44.
38. Thomsen LL, Lawton FG, Knowies RG, Beeseley JE, Riveros- Monero V and Moncada S. Nitric oxide synthase activity in human gyneocological cancer. Cancer Res. (1994) 54, 1352-1354
39. Thomsen LL, Sargent JM, Williamson CJ and Elgie AW. Nitric oxide synthase activity in fresh cells from ovarian tumor tissue: relationship of enzyme activity with clinical parameters of patients with ovarian cancer. Biochem. Pharmacol. (1998) 561: 1365-70
40. Motahari Z, Etebari M and Azizi E. Studying the role of P-glycoprotein in resistance to tamoxifen in human breast cancer T47D cells by immunocytochemistry. Int. J. Pharmacol. (2005) 1: 112-117
41. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG and Moncada S. Induction of calcium-dependent nitric oxide synthase by sex hormones. Proc. Nat. Acad. Sci. USA (1994) 91: 5212-5216
42. Yallampalli C and Dong Y. Estradiol-17-beta inhibits nitric oxide synthase (NOS)- II and stimulates NOS-III gene expression in the rat uterus. Biology of Reproduction (2000) 63: 34-41
43. Yoshie Y and Ohshima H. Synergistic induction of DNA strands breakage by catechol-estrogen and nitric oxide: implications for hormonal carcinogenesis. Free Radical Biol. Med. (1998) 24: 341-348
44. Zhi-Ming S, Waldermar J, Radzisewski S and Barsky H. Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in-vitro by two different effectors mechanisms. Cancer Let. (2000) 157: 133-144